Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.72
-0.03-1.71%
At close: -
$1.64
-0.08-4.65%
After Hours: Nov 8, 5:27 PM EDT
Comments
Loading...
Entera Bio (NASDAQ:ENTX) Stock, Analyst Ratings, Price Targets, Forecasts
Entera Bio Ltd has a consensus price target of $7.5 based on the ratings of 2 analysts. The high is $10 issued by HC Wainwright & Co. on October 7, 2024. The low is $5 issued by B. Riley Securities on July 19, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on October 7, 2024, September 27, 2024, and August 12, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 509.76% upside for Entera Bio Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for Entera Bio
Data brought to you by Benzinga APIs
FAQ
What is the target price for Entera Bio (ENTX) stock?
The latest price target for Entera Bio (NASDAQ:ENTX) was reported by HC Wainwright & Co. on October 7, 2024. The analyst firm set a price target for $10.00 expecting ENTX to rise to within 12 months (a possible 509.76% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Entera Bio (ENTX)?
The latest analyst rating for Entera Bio (NASDAQ:ENTX) was provided by HC Wainwright & Co., and Entera Bio reiterated their buy rating.
When was the last upgrade for Entera Bio (ENTX)?
There is no last upgrade for Entera Bio
When was the last downgrade for Entera Bio (ENTX)?
There is no last downgrade for Entera Bio.
When is the next analyst rating going to be posted or updated for Entera Bio (ENTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Entera Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Entera Bio was filed on October 7, 2024 so you should expect the next rating to be made available sometime around October 7, 2025.
Is the Analyst Rating Entera Bio (ENTX) correct?
While ratings are subjective and will change, the latest Entera Bio (ENTX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Entera Bio (ENTX) is trading at is $1.64, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.